🔍

Gayatri BioOrganics Ltd (524564)

📊 BSE: 524564 🏢 Commodity Chemicals 📢 Latest filing: 05 Aug 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q4 FY26)

In its latest reported quarter, Q4 FY26, Gayatri BioOrganics' revenue was ₹0.0 Cr, and net profit ₹-0.4 Cr (a bigger loss than a year earlier).

Q4 FY26 (₹ Cr)	Value	YoY vs Q4 FY25	QoQ
Revenue	₹0.0	—	—
Operating profit	₹-0.3	loss widened	loss widened
Net profit	₹-0.4	loss widened	loss widened
EPS (₹)	-0.05	loss widened	loss widened

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Resignation of Chairman Venkata Sandeep Kumar Reddy Effective August 5, 2026

🔴 NEGATIVE ⭐ 7/10

MANAGEMENT 📅 05 Aug 2026, 05:50 PM

Mr. Venkata Sandeep Kumar Reddy Tikkavarapu has resigned as Chairman and Non-Executive Director of Gayatri BioOrganics Ltd, effective August 5, 2026. The resignation occurs while the company is in severe financial distress, reporting zero revenue for the last four quarters and a negative net worth of ₹37 Cr. The outgoing Chairman cited professional responsibilities and personal reasons for his departure. This leadership exit follows a significant 62.5% decline in the company's share price over the past three months.

Resignation of the Chairman is effective from August 5, 2026
Company reported ₹0.0 Cr revenue for the trailing twelve months (TTM)
Net worth is currently negative at ₹-37 Cr with a debt of ₹38 Cr
Share price has seen a sharp decline of 62.5% over the last 3 months

💡 Investors should monitor for the appointment of a successor and any management commentary regarding the resumption of business operations, given the current zero-revenue status.

Gayatri BioOrganics reports Rs 2.34 Cr revenue in Q1; proposes name change and leadership shift

🔵 WATCH ⭐ 7/10

MANAGEMENT 📅 04 Aug 2026, 06:19 PM

Gayatri BioOrganics reported a revenue of Rs 2.34 Cr for the quarter ended June 30, 2026, marking a significant shift from zero revenue in the preceding four quarters. The company is undergoing a major transition, proposing a name change to 'Ananth BioOrganics Limited' and announcing the resignation of its Chairman, Mr. Venkata Sandeep Kumar Reddy. Mr. Sreedhara Reddy Kanaparthi has been elevated to Chairman and Managing Director for a three-year term. Despite the revenue resumption, the company remains loss-making with a net loss of Rs 0.10 Cr and a deeply negative net worth of Rs 37 Cr.

Revenue from operations stood at Rs 2.34 Cr in Q1 FY27, compared to zero revenue in the previous four quarters.
Net loss narrowed to Rs 0.10 Cr for the quarter ended June 30, 2026, from a loss of Rs 0.26 Cr in the same period last year.
Chairman Mr. Venkata Sandeep Kumar Reddy resigned effective August 5, 2026, citing personal reasons.
Mr. Sreedhara Reddy Kanaparthi appointed as Chairman and Managing Director for a 3-year term starting August 5, 2026.
Company net worth remains negative at Rs -37.00 Cr, with financials prepared on a 'going concern' basis supported by promoter comfort letters.

💡 Investors should monitor the sustainability of the newly generated revenue and check for any capital infusion or debt restructuring plans in the upcoming AGM on September 23, 2026.

Gayatri BioOrganics reports Rs 2.34 Cr revenue in Q1; proposes name change and leadership shift

🔵 WATCH ⭐ 7/10

EARNINGS 📅 04 Aug 2026, 06:10 PM

Gayatri BioOrganics reported a revenue of Rs 2.34 Cr for the quarter ended June 30, 2026, a significant shift from zero revenue in the previous four quarters. The company narrowed its net loss to Rs 0.10 Cr from a loss of Rs 0.42 Cr in the preceding quarter. Major corporate changes include a proposed name change to "Ananth BioOrganics" and the resignation of Chairman Venkata Sandeep Kumar Reddy. Mr. Sreedhara Reddy Kanaparthi has been elevated to Chairman and Managing Director for a three-year term.

Revenue from operations reached Rs 2.34 Cr in Q1 FY27, compared to zero revenue in the entire FY26.
Net loss narrowed to Rs 10.17 Lakhs from a loss of Rs 42.05 Lakhs in the March 2026 quarter.
Chairman Venkata Sandeep Kumar Reddy resigned effective August 5, 2026, citing personal reasons.
Company net worth remains deeply negative at Rs -37.00 Cr as of June 30, 2026.
Total expenses for the quarter were Rs 2.44 Cr, primarily driven by purchase of stock-in-trade worth Rs 2.15 Cr.

💡 Monitor the sustainability of the new revenue stream in upcoming quarters and the outcome of the AGM on September 23, 2026, regarding the rebranding and management transition.

Gayatri BioOrganics Reports ₹2.33 Cr Revenue in Q1 FY27; Proposes Name Change and New CMD

🔵 WATCH ⭐ 7/10

EARNINGS 📅 04 Aug 2026, 06:05 PM

Gayatri BioOrganics has resumed revenue generation, reporting ₹233.66 Lakhs in Q1 FY27 after four consecutive quarters of zero revenue. The company narrowed its net loss to ₹10.17 Lakhs from ₹26.29 Lakhs in the same period last year. A significant leadership transition occurred with the resignation of Chairman Mr. Venkata Sandeep Kumar Reddy Tikkavarapu and the appointment of Mr. Sreedhara Reddy Kanaparthi as the new Chairman and Managing Director. The board also approved a name change to 'Ananth BioOrganics Limited' (or similar variants), signaling a potential brand pivot.

Revenue from operations reached ₹233.66 Lakhs in Q1 FY27, compared to zero revenue in the previous four quarters.
Net loss narrowed to ₹10.17 Lakhs for the quarter ended June 30, 2026.
Total expenses of ₹243.84 Lakhs were primarily driven by 'Purchase of Stock-In-Trade' amounting to ₹215.45 Lakhs.
Net worth remains deeply negative at ₹(3,700.49) Lakhs as of June 30, 2026.
Resignation of Chairman Mr. Venkata Sandeep Kumar Reddy Tikkavarapu effective August 5, 2026.

💡 Investors should monitor if the newly resumed revenue (which appears to be trading-led) can scale and generate sufficient margins to address the company's negative net worth of ₹37 Cr. Watch for the upcoming AGM on September 23, 2026, for further clarity on the business pivot and name change.

04.08.2026 Board Meeting to Approve Q1 FY27 Results for Gayatri BioOrganics

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 30 Jul 2026, 06:17 PM

Gayatri BioOrganics has scheduled a board meeting on August 4, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is in a distressed financial position, having reported zero revenue for the last four consecutive quarters and maintaining a negative net worth of ₹37 Cr. With a debt of ₹38 Cr against a market capitalization of ₹58 Cr, the upcoming results are critical to monitor for any signs of operational restart. The stock has significantly underperformed, declining 61.7% over the past three months.

Board meeting scheduled for 04.08.2026 to approve Q1 FY27 results.
Company reported ₹0.0 Cr revenue for the entire FY26 period.
Trading window closed from 01.07.2026 until 48 hours after result declaration.
Net worth stands at negative ₹37 Cr as per latest available data.
Total debt of ₹38 Cr exceeds the company's negative net worth.

💡 Monitor the August 4 results specifically for any resumption of revenue or operational activity, as the company has been non-operational for over a year.

View All 524564 Announcements on Live Market Tracking →